NEULANDLAB

Neuland Laboratories Share PriceNeuland Laboratories

₹1657.9
19.05 (1.16%)
As on 22 March, 2023 | 11:20 BSE: 524558 NSE: NEULANDLAB

Neuland Laboratories Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Start SIP in Neuland Laboratories

Start SIP

Neuland Laboratories Share Price

  • Over 1 Month 1.56%
  • Over 3 Month -0.7%
  • Over 6 Month 34.19%
  • Over 1 Year 42.93%

Neuland Laboratories Key Statistics

P/E Ratio 21.1
PEG Ratio 0.3
Market Cap Cr 2,127
Price to Book Ratio 2.5
EPS 50.6
Dividend 0.3
Relative Strength Index 51.93
Money Flow Index 64.46
MACD Signal 24.92
Average True Range 71.77

Neuland Laboratories Investment Rating

  • Master Rating:
  • Neuland Laboratories has an operating revenue of Rs. 1,040.00 Cr. on a trailing 12-month basis. An annual revenue de-growth of 0% needs improvement, Pre-tax margin of 9% is okay, ROE of 7% is fair but needs improvement. The company has a reasonable debt to equity of 12%, which signals a healthy balance sheet. The stock from a technical standpoint is trading close to its 50DMA and comfortably placed above its 200DMA, around 13% above 200DMA. It needs to take support around the 50 DMA level to continue further upside move. It is currently FORMING a base in its weekly chart and is trading around 10% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 98 which is a GREAT score indicating consistency in earnings, a RS Rating of 83 which is GOOD indicating the outperformance as compared to other stocks, Buyer Demand at B+ which is evident from recent demand for the stock, Group Rank of 88 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of B is close to being the best. Overall, the stock has great fundamentals and technical strength to stay in momentum.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Neuland Laboratories Financials
IndicatorDec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 269294221256
Operating Expenses Qtr Cr 215225193217
Operating Profit Qtr Cr 54692839
Depreciation Qtr Cr 13131312
Interest Qtr Cr 3333
Tax Qtr Cr 81532
Net Profit Qtr Cr 30381022

Neuland Laboratories Technicals

EMA & SMA

Current Price
₹1657.9
19.05 (1.16%)
  • Bullish Moving Average
  • ___
  • 15
  • Bearish Moving Average
  • ___
  • 1
  • 20 Day
  • 1632.91
  • 50 Day
  • 1610.07
  • 100 Day
  • 1576.4
  • 200 Day
  • 1513.19
  • 20 Day
  • 1638.62
  • 50 Day
  • 1583.79
  • 100 Day
  • 1632.9
  • 200 Day
  • 1439.92

Neuland Laboratories Resistance and Support

PIVOT
₹1635.9
Resistance
First Resistance 1654.75
Second Resistance 1670.65
Third Resistance 1689.5
RSI 51.93
MFI 64.46
MACD Single Line 24.92
MACD 20.25
Support
First Resistance 1620
Second Resistance 1601.15
Third Resistance 1585.25

Neuland Laboratories Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 15,872 504,095 31.76
Week 16,459 475,342 28.88
1 Month 29,434 1,072,883 36.45
6 Month 66,571 2,102,307 31.58

Neuland Laboratories Result Highlights

Neuland Laboratories Synopsis

NSE-Medical-Diversified

Neuland Laborat is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company’s Total Operating Revenue is Rs. 951.08 Cr. and Equity Capital is Rs. 12.90 Cr. for the Year ended 31/03/2022. Neuland Laboratories Ltd. is a Public Limited Listed company incorporated on 07/01/1984 and has its registered office in the State of Telangana, India. Company’s Corporate Identification Number(CIN) is L85195TG1984PLC004393 and registration number is 004393.
Market Cap 2,125
Sales 1,040
Shares in Float 0.82
No of funds 56
Yield 0.31
Book Value 2.53
U/D Vol ratio 1.9
LTDebt / Equity 12
Alpha 0.22
Beta 0.83

Neuland Laboratories

Owner NameDec-22Sep-22Jun-22Mar-22
Promoters 36.14%36.22%36.22%
Mutual Funds 0.79%0.79%0.79%
Foreign Portfolio Investors 17.7%17.68%17.37%
Financial Institutions/ Banks
Individual Investors 30.09%31.02%33.25%
Others 15.28%14.29%12.37%

Neuland Laboratories Management

Name Designation
Dr. Davuluri Rama Mohan Rao Executive Chairman
Mr. Davuluri Sucheth Rao Vice Chairman & CEO
Mr. Davuluri Saharsh Rao Vice Chairman & Mng.Director
Dr. Christopher M Cimarusti Non Executive Director
Mr. Humayun Dhanrajgir Ind. Non-Executive Director
Mrs. Bharati Rao Ind. Non-Executive Director
Dr. Nirmala Murthy Ind. Non-Executive Director
Mr. Parampally Vasudeva Maiya Ind. Non-Executive Director
Mr. Homi Rustum Khusrokhan Ind. Non-Executive Director

Neuland Laboratories Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Neuland Laboratories MF Shareholding

Name Amount(cr)
Quant Small Cap Fund Growth 3302
Motilal Oswal S&P BSE Healthcare ETF 6

Neuland Laboratories FAQs

What is Share Price of Neuland Laboratories ?

Neuland Laboratories share price is ₹1657 As on 22 March, 2023 | 11:06

What is the Market Cap of Neuland Laboratories ?

The Market Cap of Neuland Laboratories is ₹2127.1 Cr As on 22 March, 2023 | 11:06

What is the P/E ratio of Neuland Laboratories ?

The P/E ratio of Neuland Laboratories is 21.1 As on 22 March, 2023 | 11:06

What is the PB ratio of Neuland Laboratories ?

The PB ratio of Neuland Laboratories is 2.5 As on 22 March, 2023 | 11:06

Q2FY23

Start Investing Now!

Open Free Demat Account in 5 mins

Enter Valid Mobile Number